NCT05587751View on ClinicalTrials.gov

Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients

NARecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Hormonal Gender-Affirming Therapy
Interventions
DIAGNOSTIC_TEST

Spirometry

Pulmonary function test to measure lung function

DIAGNOSTIC_TEST

Plethysmography

Pulmonary function test to measure lung volume

Trial Locations (1)

55905

RECRUITING

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05587751 - Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients | Biotech Hunter | Biotech Hunter